Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

N

NEUP

Neuphoria Therapeutics Inc

3.81

Aug 11 • 3:49 PM ET -0.05 (-1.30%)

3.83

Aftermarket • 5:00 PM ET +0.02 (0.52%)

Healthcare Biotechnology USA Nano NASD

Peers: BCDA BIVI CALC CVM KPRX AIM APRE GOVX JAGX KAPA

| Held by: PSIL VTI VXF

Scroll to Statements

Index	-
Market Cap	20.57M
Enterprise Value	1.16M
Income	-
Sales	-
Book/sh	5.47
Cash/sh	3.60
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	8
IPO	Dec 16, 2021

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	0.70
P/C	1.06
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	14.31
Current Ratio	14.31
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	-
EPS next Y	-2.43
EPS next Q	-0.56
EPS this Y	-1669.57%
EPS next Y	40.29%
EPS next 5Y	-
EPS past 3/5Y	-17.62% -20.01%
Sales past 3/5Y	334.17% 246.61%
EPS Y/Y TTM	-15957.73%
Sales Y/Y TTM	-
EPS Q/Q	92.44%
Sales Q/Q	-100.00%
Earnings	Jun 03
EPS/Sales Surpr.	0.00% -

Insider Own	9.05%
Insider Trans	0.00%
Inst Own	36.57%
Inst Trans	8.59%
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	2.40%
SMA50	-5.23%
SMA200	-12.48%
Trades

Shs Outstand	-
Shs Float	4.92M
Short Float	1.33%
Short Ratio	0.33
Short Interest	0.07M
52W High	21.40 -82.20%
52W Low	3.19 19.44%
Volatility	3.76% 5.93%
ATR (14)	0.23
RSI (14)	48.46
Beta	0.75
Rel Volume	0.15
Avg Volume	197.71K
Volume	30,362

Perf Week	-2.06%
Perf Month	9.17%
Perf Quarter	-26.31%
Perf Half Y	-4.75%
Perf YTD	-1.80%
Perf Year	-47.08%
Perf 3Y	-78.97%
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	7.00
Prev Close	3.86
Price	3.81
Change %	-1.30%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)